Dystrophin-deficient cardiomyocytes derived from human urine: New biologic reagents for drug discovery
The ability to extract somatic cells from a patient and reprogram them to pluripotency opens up new possibilities for personalized medicine. Induced pluripotent stem cells (iPSCs) have been employed to generate beating cardiomyocytes from a patient's skin or blood cells. Here, iPSC methods were...
Main Authors: | Xuan Guan, David L. Mack, Claudia M. Moreno, Jennifer L. Strande, Julie Mathieu, Yingai Shi, Chad D. Markert, Zejing Wang, Guihua Liu, Michael W. Lawlor, Emily C. Moorefield, Tara N. Jones, James A. Fugate, Mark E. Furth, Charles E. Murry, Hannele Ruohola-Baker, Yuanyuan Zhang, Luis F. Santana, Martin K. Childers |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-03-01
|
Series: | Stem Cell Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1873506113001827 |
Similar Items
-
Differentiation Capacity of Human Urine-Derived Stem Cells to Retain Telomerase Activity
by: Yingai Shi, et al.
Published: (2022-05-01) -
Dystrophin is required for the normal function of the cardio-protective K(ATP) channel in cardiomyocytes.
by: Laura Graciotti, et al.
Published: (2011-01-01) -
Transfection of hPSC-Cardiomyocytes Using Viafect™ Transfection Reagent
by: Sara E. Bodbin, et al.
Published: (2020-08-01) -
Complete restoration of multiple dystrophin isoforms in genetically corrected Duchenne muscular dystrophy patient–derived cardiomyocytes
by: Susi Zatti, et al.
Published: (2014-01-01) -
Calcium handling maturation and adaptation to increased substrate stiffness in human iPSC-derived cardiomyocytes: The impact of full-length dystrophin deficiency
by: Josè Manuel Pioner, et al.
Published: (2022-11-01)